Tiplaxtinin (PAI-039)
Catalog No. A14190
Tiplaxtinin (PAI-039)是一种纤溶酶原激活物抑制剂1(PAI-1)的选择性口服有效抑制剂,IC50为2.7μM。
- Saijo A, .et al. Bone marrow-derived fibrocytes promote stem cell-like properties of lung cancer cells, Cancer Lett, 2018, May 1;421:17-27 PMID: 29448000
Catalog Num | A14190 |
---|---|
M. Wt | 439.3833 |
Formula | C24H16F3NO4 |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 393105-53-8 |
Synonyms | PAI-039 |
SMILES | C1=CC=C(C=C1)CN2C=C(C3=C2C=CC(=C3)C4=CC=C(C=C4)OC(F)(F)F)C(=O)C(=O)O |
Tiplaxtinin (PAI-039)是一种纤溶酶原激活物抑制剂1(PAI-1)的选择性口服有效抑制剂,IC50为2.7μM。
Targets
PAI-1 | ||||
2.7 μM |
In vitro (25°C) | DMSO | 62 mg/mL (141.1 mM) | |
Water | Insoluble | ||
Ethanol | Warmed: 15 mg/mL (34.13 mM) | ||
In vivo | 2.0% Tween 80+0.5% methylcellulose | 28 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 22.76 mL | 113.8 mL | 227.59 mL |
0.5 mM | 4.55 mL | 22.76 mL | 45.52 mL |
1 mM | 2.28 mL | 11.38 mL | 22.76 mL |
5 mM | 0.46 mL | 2.28 mL | 4.55 mL |
*The above data is based on the productmolecular weight 439.3833. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.